Stock Information
NewAmsterdam Pharma Company NV (NAMS)
Ticker Symbol: NAMS
Exchange: NASDAQ
Sector: N/A
Market Cap: $0.00 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.019
Revenue (TTM): $0.30 M
Dividend Yield: N/A%
ROE: -29.07%
Latest News
-
The Bull Case For NewAmsterdam Pharma (NAMS) Could Change Following 2025 Results And New Share Offering
Mon, Feb 23, 2026 11:05 AM
-
Guggenheim Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $45
Thu, Feb 19, 2026 10:32 AM
Key Financials
Financial data not available